Rationally Designed Aberrant Kinase-Targeted Endogenous Protein Nanomedicine against Oncogene Mutated/Amplified Refractory Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Rationally Designed Aberrant Kinase-Targeted Endogenous Protein Nanomedicine against Oncogene Mutated/Amplified Refractory Chronic Myeloid Leukemia

Published:2012-10-05 Issue:11 Volume:9 Page:3062-3078
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Retnakumari Archana P.¹,Hanumanthu Prasanna Lakshmi¹,Malarvizhi Giridharan L.¹,Prabhu Raghuveer¹,Sidharthan Neeraj¹,Thampi Madhavan V.¹,Menon Deepthy¹,Mony Ullas¹,Menon Krishnakumar¹,Keechilat Pavithran¹,Nair Shantikumar¹,Koyakutty Manzoor¹

Affiliation:

1. Amrita Center for Nanosciences and Molecular Medicine, ‡Department of Medical Oncology, and §Department of Human Cytogenetics, Amrita Institute of Medical Science and Research Center, Amrita Vishwavidyapeetham University, Cochin, India

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp300172e

Reference48 articles.

1. Protein kinases — the major drug targets of the twenty-first century?

2. High Frequency of Mutations of the PIK3CA Gene in Human Cancers

3. Mutations of the BRAF gene in human cancer

4. The molecular biology of chronic myeloid leukemia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox-responsive nanomedicine of doxorubicin-conjugated poly-L-glutathione oxidized for cancer therapy;Journal of the Taiwan Institute of Chemical Engineers;2024-06

2. Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2;Biology;2023-10-16

3. 5-FU mediated depletion of myeloid suppressor cells enhances T-cell infiltration and anti-tumor response in immunotherapy–resistant lung tumor;International Immunopharmacology;2023-07

4. Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core–shell protein nanoparticle;Drug Delivery and Translational Research;2022-06-09

5. Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective;International Journal of Molecular Sciences;2021-06-18